These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 38892293)

  • 1. The Role of MicroRNA in the Pathogenesis of Duchenne Muscular Dystrophy.
    Kiełbowski K; Bakinowska E; Procyk G; Ziętara M; Pawlik A
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The X-linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45-47.
    Heier CR; McCormack NM; Tully CB; Novak JS; Newell-Stamper BL; Russell AJ; Fiorillo AA
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):940-954. PubMed ID: 36628607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncoding RNAs in Duchenne and Becker muscular dystrophies: role in pathogenesis and future prognostic and therapeutic perspectives.
    Brusa R; Magri F; Bresolin N; Comi GP; Corti S
    Cell Mol Life Sci; 2020 Nov; 77(21):4299-4313. PubMed ID: 32350552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker Potential of Extracellular miRNAs in Duchenne Muscular Dystrophy.
    Coenen-Stass AML; Wood MJA; Roberts TC
    Trends Mol Med; 2017 Nov; 23(11):989-1001. PubMed ID: 28988850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
    Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
    Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR/Cas9.
    Sui T; Lau YS; Liu D; Liu T; Xu L; Gao Y; Lai L; Li Z; Han R
    Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29871865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20.
    Mata López S; Hammond JJ; Rigsby MB; Balog-Alvarez CJ; Kornegay JN; Nghiem PP
    Skelet Muscle; 2018 May; 8(1):16. PubMed ID: 29843823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The discovery of dystrophin, the protein product of the Duchenne muscular dystrophy gene.
    Hoffman EP
    FEBS J; 2020 Sep; 287(18):3879-3887. PubMed ID: 32608079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional and epigenetic analyses of the DMD locus reveal novel cis‑acting DNA elements that govern muscle dystrophin expression.
    Gherardi S; Bovolenta M; Passarelli C; Falzarano MS; Pigini P; Scotton C; Neri M; Armaroli A; Osman H; Selvatici R; Gualandi F; Recchia A; Mora M; Bernasconi P; Maggi L; Morandi L; Ferlini A; Perini G
    Biochim Biophys Acta Gene Regul Mech; 2017 Nov; 1860(11):1138-1147. PubMed ID: 28867298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the process of fibrosis in Duchenne muscular dystrophy.
    Kharraz Y; Guerra J; Pessina P; Serrano AL; Muñoz-Cánoves P
    Biomed Res Int; 2014; 2014():965631. PubMed ID: 24877152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing.
    Hanson B; Wood MJA; Roberts TC
    RNA Biol; 2021 Jul; 18(7):1048-1062. PubMed ID: 33472516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mouse model of Duchenne muscular dystrophy carrying a multi-exonic
    Wong TWY; Ahmed A; Yang G; Maino E; Steiman S; Hyatt E; Chan P; Lindsay K; Wong N; Golebiowski D; Schneider J; Delgado-Olguín P; Ivakine EA; Cohn RD
    Dis Model Mech; 2020 Sep; 13(9):. PubMed ID: 32988972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-level dystrophin expression attenuating the dystrophinopathy phenotype.
    Waldrop MA; Gumienny F; El Husayni S; Frank DE; Weiss RB; Flanigan KM
    Neuromuscul Disord; 2018 Feb; 28(2):116-121. PubMed ID: 29305136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy.
    Echigoya Y; Lim KRQ; Trieu N; Bao B; Miskew Nichols B; Vila MC; Novak JS; Hara Y; Lee J; Touznik A; Mamchaoui K; Aoki Y; Takeda S; Nagaraju K; Mouly V; Maruyama R; Duddy W; Yokota T
    Mol Ther; 2017 Nov; 25(11):2561-2572. PubMed ID: 28865998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.
    Ahmad A; Brinson M; Hodges BL; Chamberlain JS; Amalfitano A
    Hum Mol Genet; 2000 Oct; 9(17):2507-15. PubMed ID: 11030755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy.
    Larcher T; Lafoux A; Tesson L; Remy S; Thepenier V; François V; Le Guiner C; Goubin H; Dutilleul M; Guigand L; Toumaniantz G; De Cian A; Boix C; Renaud JB; Cherel Y; Giovannangeli C; Concordet JP; Anegon I; Huchet C
    PLoS One; 2014; 9(10):e110371. PubMed ID: 25310701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy.
    Starosta A; Konieczny P
    Cell Mol Life Sci; 2021 Jun; 78(11):4867-4891. PubMed ID: 33825942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.